myristic acid has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabot, MC; Giuliano, AE; Zhang, ZC | 1 |
| Kimura, T; Murayama, K; Nakano, T; Okabe, M; Umehara, H; Watanabe, S | 1 |
2 other study(ies) available for myristic acid and tamoxifen
| Article | Year |
|---|---|
Tamoxifen elicits rapid transmembrane lipid signal responses in human breast cancer cells.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Lipid Metabolism; Lipids; Membranes; Myristic Acid; Myristic Acids; Phosphatidic Acids; Second Messenger Systems; Signal Transduction; Tamoxifen; Tumor Cells, Cultured | 1995 |
Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells.
Topics: Animals; beta Catenin; Cell Culture Techniques; Cell Differentiation; Cell Proliferation; Embryo, Mammalian; Enzyme Activation; Estrogen Antagonists; Interleukin-6; Leukemia Inhibitory Factor; Macaca fascicularis; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myristic Acid; Phenotype; Pluripotent Stem Cells; Proto-Oncogene Proteins c-akt; Recombinant Fusion Proteins; Signal Transduction; STAT3 Transcription Factor; Tamoxifen | 2006 |